Myeloma: Immune response may predict progression

816 views · Published 4 December 2018 · 1:46 · Indexed 5 October 2026

Channel: Dana-Farber Cancer Institute · 2018 · Science & Technology

Watch on YouTube

Before symptoms of multiple myeloma develop, Dana-Farber Cancer Institute researchers say a patient’s risk of progression might be tied to certain precursor conditions. 
The findings were presented at the American Society of Hematology Annual Meeting.
The research looked at the precursors Monoclonal Gammopathy of Undetermined Significance or M-GUS and smoldering multiple myeloma.

More from this channel

• 0:18 Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute

  Dana-Farber Cancer Institute

  202 views · 9 November 2007

• 0:20 How to Join the Stem Cell Registry | Dana-Farber Cancer Institute

  Dana-Farber Cancer Institute

  232 views · 9 November 2007

• 0:18 How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute

  Dana-Farber Cancer Institute

  262 views · 9 November 2007

• 3:03 Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute

  Dana-Farber Cancer Institute

  532 views · 9 November 2007

• 0:07 Dana-Farber Banners | Dana-Farber Cancer Institute

  Dana-Farber Cancer Institute

  325 views · 11 November 2007

• 2:08 Barbers for the Jimmy Fund | Dana-Farber Cancer Institute

  Dana-Farber Cancer Institute

  514 views · 12 November 2007

• 1:43 Pets | Dana-Farber Cancer Institute

  Dana-Farber Cancer Institute

  605 views · 12 November 2007

• 1:34 Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute

  Dana-Farber Cancer Institute

  457 views · 28 November 2007